Medical Minute 2: Holistic MS Management
  • CE

Hear expert faculty discuss the most important considerations when starting or stopping disease modifying therapies in patients with MS.
person default
Lisa Aquillano, PharmD, BCPS, MSCS
person default
Calli Cook, DNP, APRN, FNP-C, FAANP
Nurse Practitioners: 0.67 AANP contact hours
Released: August 1, 2020 Expiration: August 1, 2021

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Utilize currently available agents to initiate and modify MS therapy in accordance with the most recent guidelines and evidence.

Acknowledgements

Provided by the American Association of Nurse Practitioners (AANP).

AANP CE Center Manager
CECenter@aanp.org

Supported by educational grants from
Biogen
Genentech, a member of the Roche Group
Novartis Pharmaceuticals Corporation
Sanofi Genzyme Corporation

Information on this Educational Activity

Faculty

Lisa Aquillano, PharmD, BCPS, MSCS

Clinical Pharmacy Specialist
Multiple Sclerosis
Emory University Hospital

Lisa Aquillano, PharmD, BCPS, MSCS has no relevant conflicts of interest to report.
Calli Cook, DNP, APRN, FNP-C, FAANP

Clinical Assistant Professor
Emory University, NHWSON
Nurse Practitioner
Emory Brain Health Center

 

 

Calli Cook, DNP, APRN, FNP-C, FAANP has no relevant conflicts of interest to report.

Staff

Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Anne Roc, PhD
Director, Scientific Services
Anne Roc, PhD, has no relevant conflicts of interest to report.
Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Target Audience

This initiative is intended for NPs involved in managing patients with multiple sclerosis (MS).

Goal

The goal of these educational activities is to improve knowledge and competence among NPs in diagnosing and managing MS in a primary care setting.

AANP Credit

CE Statement

This activity is approved for 0.67 contact hours of continuing education (which includes 0.67 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID# 1137-1141-1144-1145. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Program Medium

This program has been made available online.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue